ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $10,881,365 | +55.4% | 588,500 | +96.2% | 0.35% | +135.6% |
| Q4 2021 | $7,002,000 | -23.4% | 300,000 | -45.5% | 0.15% | -26.2% |
| Q3 2021 | $9,136,000 | -60.2% | 550,000 | -41.5% | 0.20% | -67.4% |
| Q2 2021 | $22,927,000 | -18.7% | 940,000 | +78.2% | 0.62% | -32.3% |
| Q4 2020 | $28,205,000 | +87.0% | 527,600 | +47.8% | 0.92% | -56.0% |
| Q1 2020 | $15,083,000 | +552.9% | 357,000 | +561.1% | 2.08% | +43.1% |
| Q4 2019 | $2,310,000 | – | 54,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |